Literature DB >> 7543776

Identification of the peptide binding motif for HLA-B44, one of the most common HLA-B alleles in the Caucasian population.

M DiBrino1, K C Parker, D H Margulies, J Shiloach, R V Turner, W E Biddison, J E Coligan.   

Abstract

Most peptides that bind to a particular MHC class I molecule share amino acid residues that are thought to physically "anchor" the peptide to polymorphic pockets within the class I binding site. Sequence analysis of endogenous peptides bound to HLA-B44 revealed two potential dominant anchor residues: Glu at P2 and Tyr, or occasionally Phe, at P9. In vitro assembly assays employing synthetic peptides and recombinant HLA-B44 produced by Escherichia coli revealed that an acidic amino acid at P2 was necessary for promoting stable peptide binding to HLA-B44. Surprisingly, although Tyr was almost exclusively found at P9 of the endogenous peptide sequences, a wide variety of amino acid residues such as Leu, Ala, Arg, Lys, His, and Phe could be tolerated at this position. Using this information, we identified antigenic peptides from the influenza virus components nonstructural protein 1 and nucleoprotein that are presented by HLA-B44 to antiinfluenza type A cytotoxic T lymphocytes. In addition, cytotoxic T lymphocytes induced by these antigenic peptides were shown to be capable of recognizing endogenously processed peptides from influenza-infected cells, indicating a potential use for these peptides in vaccine development. Finally, molecular models were created to investigate the possible ways in which the anchor residues might function to stabilize the binding of peptides to HLA-B44, and these models indicate that the acidic residue at P2 most likely interacts primarily with Lys 45 of the HLA-B44 heavy chain and makes additional contacts with Ser 67 and Tyr 9.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7543776     DOI: 10.1021/bi00032a005

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  23 in total

1.  Evidence for rapid disappearance of initially expanded HIV-specific CD8+ T cell clones during primary HIV infection.

Authors:  G Pantaleo; H Soudeyns; J F Demarest; M Vaccarezza; C Graziosi; S Paolucci; M Daucher; O J Cohen; F Denis; W E Biddison; R P Sekaly; A S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-02       Impact factor: 11.205

2.  The human leukocyte antigen-presented ligandome of B lymphocytes.

Authors:  Chopie Hassan; Michel G D Kester; Arnoud H de Ru; Pleun Hombrink; Jan Wouter Drijfhout; Harm Nijveen; Jack A M Leunissen; Mirjam H M Heemskerk; J H Frederik Falkenburg; Peter A van Veelen
Journal:  Mol Cell Proteomics       Date:  2013-03-12       Impact factor: 5.911

3.  Human cytotoxic T lymphocytes directed to seasonal influenza A viruses cross-react with the newly emerging H7N9 virus.

Authors:  Carolien E van de Sandt; Joost H C M Kreijtz; Gerrie de Mutsert; Martina M Geelhoed-Mieras; Marine L B Hillaire; Stella E Vogelzang-van Trierum; Albert D M E Osterhaus; Ron A M Fouchier; Guus F Rimmelzwaan
Journal:  J Virol       Date:  2013-11-20       Impact factor: 5.103

4.  Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy.

Authors:  Diego Chowell; Luc G T Morris; Claud M Grigg; Jeffrey K Weber; Robert M Samstein; Vladimir Makarov; Fengshen Kuo; Sviatoslav M Kendall; David Requena; Nadeem Riaz; Benjamin Greenbaum; James Carroll; Edward Garon; David M Hyman; Ahmet Zehir; David Solit; Michael Berger; Ruhong Zhou; Naiyer A Rizvi; Timothy A Chan
Journal:  Science       Date:  2017-12-07       Impact factor: 47.728

5.  Proteomics in Vaccinology and Immunobiology: An Informatics Perspective of the Immunone.

Authors:  Irini A. Doytchinova; Paul Taylor; Darren R. Flower
Journal:  J Biomed Biotechnol       Date:  2003

6.  Functional constraints of influenza A virus epitopes limit escape from cytotoxic T lymphocytes.

Authors:  E G M Berkhoff; E de Wit; M M Geelhoed-Mieras; A C M Boon; J Symons; R A M Fouchier; A D M E Osterhaus; G F Rimmelzwaan
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

7.  A recombinant adenovirus expressing an Epstein-Barr virus (EBV) target antigen can selectively reactivate rare components of EBV cytotoxic T-lymphocyte memory in vitro.

Authors:  S M Morgan; G W Wilkinson; E Floettmann; N Blake; A B Rickinson
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

8.  Dominant recognition by human CD8+ cytotoxic T lymphocytes of dengue virus nonstructural proteins NS3 and NS1.2a.

Authors:  A Mathew; I Kurane; A L Rothman; L L Zeng; M A Brinton; F A Ennis
Journal:  J Clin Invest       Date:  1996-10-01       Impact factor: 14.808

9.  HLA-A*01:03, HLA-A*24:02, HLA-B*08:01, HLA-B*27:05, HLA-B*35:01, HLA-B*44:02, and HLA-C*07:01 monochain transgenic/H-2 class I null mice: novel versatile preclinical models of human T cell responses.

Authors:  Rachid Boucherma; Hédia Kridane-Miledi; Romain Bouziat; Michael Rasmussen; Tanja Gatard; Francina Langa-Vives; Brigitte Lemercier; Annick Lim; Marion Bérard; Lbachir Benmohamed; Søren Buus; Ronald Rooke; François A Lemonnier
Journal:  J Immunol       Date:  2013-06-17       Impact factor: 5.422

10.  Natural micropolymorphism in human leukocyte antigens provides a basis for genetic control of antigen recognition.

Authors:  Julia K Archbold; Whitney A Macdonald; Stephanie Gras; Lauren K Ely; John J Miles; Melissa J Bell; Rebekah M Brennan; Travis Beddoe; Matthew C J Wilce; Craig S Clements; Anthony W Purcell; James McCluskey; Scott R Burrows; Jamie Rossjohn
Journal:  J Exp Med       Date:  2009-01-12       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.